Abstract
Zinc is abundant in the central nervous system and regulates pain, but the underlying mechanisms are unknown. In vitro studies have shown that extracellular zinc modulates a plethora of signaling membrane proteins, including NMDA receptors containing the NR2A subunit, which display exquisite zinc sensitivity. We created NR2A-H128S knock-in mice to investigate whether Zn2+–NR2A interaction influences pain control. In these mice, high-affinity (nanomolar) zinc inhibition of NMDA currents was lost in the hippocampus and spinal cord. Knock-in mice showed hypersensitivity to radiant heat and capsaicin, and developed enhanced allodynia in inflammatory and neuropathic pain models. Furthermore, zinc-induced analgesia was completely abolished under both acute and chronic pain conditions. Our data establish that zinc is an endogenous modulator of excitatory neurotransmission in vivo and identify a new mechanism in pain processing that relies on NR2A NMDA receptors. The study also potentially provides a molecular basis for the pain-relieving effects of dietary zinc supplementation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hambidge, K.M. & Krebs, N.F. Zinc deficiency: a special challenge. J. Nutr. 137, 1101–1105 (2007).
Frederickson, C.J., Suh, S.W., Silva, D. & Thompson, R.B. Importance of zinc in the central nervous system: the zinc-containing neuron. J. Nutr. 130, 1471S–1483S (2000).
Vogt, K., Mellor, J., Tong, G. & Nicoll, R. The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron 26, 187–196 (2000).
Ma, J.Y. & Zhao, Z.Q. The effects of Zn2+ on long-term potentiation of C fiber-evoked potentials in the rat spinal dorsal horn. Brain Res. Bull. 56, 575–579 (2001).
Ueno, S. et al. Mossy fiber Zn2+ spillover modulates heterosynaptic N-methyl-D-aspartate receptor activity in hippocampal CA3 circuits. J. Cell Biol. 158, 215–220 (2002).
Kodirov, S.A. et al. Synaptically released zinc gates long-term potentiation in fear conditioning pathways. Proc. Natl. Acad. Sci. USA 103, 15218–15223 (2006).
Hirzel, K. et al. Hyperekplexia phenotype of glycine receptor alpha1 subunit mutant mice identifies Zn(2+) as an essential endogenous modulator of glycinergic neurotransmission. Neuron 52, 679–690 (2006).
Sensi, S.L., Paoletti, P., Bush, A.I. & Sekler, I. Zinc in the physiology and pathology of the CNS. Nat. Rev. Neurosci. 10, 780–791 (2009).
Velázquez, R.A., Cai, Y., Shi, Q. & Larson, A.A. The distribution of zinc selenite and expression of metallothionein-III mRNA in the spinal cord and dorsal root ganglia of the rat suggest a role for zinc in sensory transmission. J. Neurosci. 19, 2288–2300 (1999).
Jo, S.M., Danscher, G., Schroder, H.D. & Suh, S.W. Depletion of vesicular zinc in dorsal horn of spinal cord causes increased neuropathic pain in mice. Biometals 21, 151–158 (2008).
Smart, T.G., Hosie, A.M. & Miller, P.S. Zn2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist 10, 432–442 (2004).
Frederickson, C.J., Koh, J.Y. & Bush, A.I. The neurobiology of zinc in health and disease. Nat. Rev. Neurosci. 6, 449–462 (2005).
Paoletti, P., Vergnano, A.M., Barbour, B. & Casado, M. Zinc at glutamatergic synapses. Neuroscience 158, 126–136 (2009).
Traynelis, S.F. et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 62, 405–496 (2010).
Woolf, C.J. & Salter, M.W. Neuronal plasticity: increasing the gain in pain. Science 288, 1765–1769 (2000).
Latremoliere, A. & Woolf, C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 10, 895–926 (2009).
Paoletti, P., Ascher, P. & Neyton, J. High-affinity zinc inhibition of NMDA NR1–NR2A receptors. J. Neurosci. 17, 5711–5725 (1997).
Paoletti, P. et al. Molecular organization of a zinc binding n-terminal modulatory domain in a NMDA receptor subunit. Neuron 28, 911–925 (2000).
Fayyazuddin, A., Villarroel, A., Le Goff, A., Lerma, J. & Neyton, J. Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors. Neuron 25, 683–694 (2000).
Low, C.M., Zheng, F., Lyuboslavsky, P. & Traynelis, S.F. Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors. Proc. Natl. Acad. Sci. USA 97, 11062–11067 (2000).
Gielen, M., Siegler Retchless, B., Mony, L., Johnson, J.W. & Paoletti, P. Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 459, 703–707 (2009).
Scherrer, G. et al. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc. Natl. Acad. Sci. USA 103, 9691–9696 (2006).
Cole, T.B., Wenzel, H.J., Kafer, K.E., Schwartzkroin, P.A. & Palmiter, R.D. Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc. Natl. Acad. Sci. USA 96, 1716–1721 (1999).
Basbaum, A.I., Bautista, D.M., Scherrer, G. & Julius, D. Cellular and molecular mechanisms of pain. Cell 139, 267–284 (2009).
Yeomans, D.C., Pirec, V. & Proudfit, H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: behavioral evidence. Pain 68, 133–140 (1996).
Le Bars, D., Gozariu, M. & Cadden, S.W. Animal models of nociception. Pharmacol. Rev. 53, 597–652 (2001).
Drdla, R. & Sandkuhler, J. Long-term potentiation at C-fibre synapses by low-level presynaptic activity in vivo. Mol. Pain 4, 18 (2008).
Matsumoto, M., Kondo, S., Usdin, T.B. & Ueda, H. Parathyroid hormone 2 receptor is a functional marker of nociceptive myelinated fibers responsible for neuropathic pain. J. Neurochem. 112, 521–530 (2010).
Svensson, C.I., Hua, X.Y., Protter, A.A., Powell, H.C. & Yaksh, T.L. Spinal p38 MAP kinase is necessary for NMDA-induced spinal PGE(2) release and thermal hyperalgesia. Neuroreport 14, 1153–1157 (2003).
Yaksh, T.L., Hua, X.Y., Kalcheva, I., Nozaki-Taguchi, N. & Marsala, M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc. Natl. Acad. Sci. USA 96, 7680–7686 (1999).
Vardeh, D. et al. COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. J. Clin. Invest. 119, 287–294 (2009).
Hu, H., Bandell, M., Petrus, M.J., Zhu, M.X. & Patapoutian, A. Zinc activates damage-sensing TRPA1 ion channels. Nat. Chem. Biol. 5, 183–190 (2009).
Larson, A.A. & Kitto, K.F. Manipulations of zinc in the spinal cord, by intrathecal injection of zinc chloride, disodium-calcium-EDTA, or dipicolinic acid, alter nociceptive activity in mice. J. Pharmacol. Exp. Ther. 282, 1319–1325 (1997).
Safieh-Garabedian, B. et al. Zinc reduces the hyperalgesia and upregulation of NGF and IL-1 beta produced by peripheral inflammation in the rat. Neuropharmacology 35, 599–603 (1996).
Liu, T., Walker, J.S. & Tracey, D.J. Zinc alleviates thermal hyperalgesia due to partial nerve injury. Neuroreport 10, 1619–1623 (1999).
Sendur, O.F., Tastaban, E., Turan, Y. & Ulman, C. The relationship between serum trace element levels and clinical parameters in patients with fibromyalgia. Rheumatol. Int. 28, 1117–1121 (2008).
Head, K.A. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern. Med. Rev. 11, 294–329 (2006).
Yoshida, H., Tsuji, K., Sakata, T., Nakagawa, A. & Morita, S. Clinical study of tongue pain: Serum zinc, vitamin B12, folic acid, and copper concentrations, and systemic disease. Br. J. Oral Maxillofac. Surg. 48, 469–472 (2010).
Al-Hallaq, R.A., Conrads, T.P., Veenstra, T.D. & Wenthold, R.J. NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. J. Neurosci. 27, 8334–8343 (2007).
Rauner, C. & Kohr, G. Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate (NMDA) receptor population in adult hippocampal synapses. J. Biol. Chem. 286, 7558–7566 (2010).
Hatton, C.J. & Paoletti, P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46, 261–274 (2005).
Mony, L., Kew, J.N., Gunthorpe, M.J. & Paoletti, P. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br. J. Pharmacol. 157, 1301–1317 (2009).
Danscher, G. et al. Inhibitory zinc-enriched terminals in mouse spinal cord. Neuroscience 105, 941–947 (2001).
Sandkühler, J. Understanding LTP in pain pathways. Mol. Pain 3, 9 (2007).
Miledi, R., Eusebi, F., Martinez-Torres, A., Palma, E. & Trettel, F. Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes. Proc. Natl. Acad. Sci. USA 99, 13238–13242 (2002).
Boyce, S. et al. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38, 611–623 (1999).
Ma, Q.P. & Hargreaves, R.J. Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience 101, 699–707 (2000).
Gaveriaux-Ruff, C. et al. Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 152, 1238–1248 (2011).
Sakurada, T., Katsumata, K., Tan-No, K., Sakurada, S. & Kisara, K. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology 31, 1279–1285 (1992).
Acknowledgements
We thank B. Puvion, A. Matifas and R. Weibel for technical assistance and E. Krejci for help with the targeting vector. We thank B. Barbour, J. Becker and E. Schwartz for comments on the manuscript. We also thank Victor Faundez (Emory University) for the gift of the ZnT3 antibody. This research was supported by the Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), the Université de Strasbourg, the Agence Nationale de la Recherche (France) grant SynapticZinc (P.P. and B.K.), the US National Institutes of Health, National Institue on Drug Abuse grant DA05010 (B.K.) and an Equipe Fondation pour la Recherche Médicale (FRM) grant (P.P.). C.N. was supported by the FRM and A.M.V. by the Région Ile-de-France.
Author information
Authors and Affiliations
Contributions
B.L.K. and P.P. designed and supervised the study. D.F., J.N. and A.L.G. contributed to the creation NR2A-H128S mutant mouse line. J.N. and P.P. performed the electrophysiologial experiments on Xenopus oocytes. A.M.V. ran electrophysiological characterization of mutant mice and performed the Timm's staining. C.N. performed all of the pain experiments. D.R. and A.-M.O. conducted neurological examination of mutant mice. S.C. and A.M.V. performed immunochemistry. C.G.-R. and J.N. contributed to conceptual aspects of the study. C.N., A.M.V., C.G.-R., A.-M.O., P.P. and B.L.K. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8 and Supplementary Table 1 (PDF 1037 kb)
Rights and permissions
About this article
Cite this article
Nozaki, C., Vergnano, A., Filliol, D. et al. Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit. Nat Neurosci 14, 1017–1022 (2011). https://doi.org/10.1038/nn.2844
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.2844
This article is cited by
-
Expression analysis of zinc-metabolizing enzymes in the saliva as a new method of evaluating zinc content in the body: two case reports and a review of the literature
Journal of Medical Case Reports (2024)
-
The Therapeutic Potential of Antioxidants in Chemotherapy-Induced Peripheral Neuropathy: Evidence from Preclinical and Clinical Studies
Neurotherapeutics (2023)
-
Recent advances in pain management based on nanoparticle technologies
Journal of Nanobiotechnology (2022)
-
GluN2A and GluN2B NMDA receptors use distinct allosteric routes
Nature Communications (2021)
-
Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling
Translational Psychiatry (2021)